Skip to main content


Figure 1 | Breast Cancer Research

Figure 1

From: 17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration

Figure 1

Proteomic analysis of wild type (WT) MCF7 cells and MCF7 cells stably transfected with 17β-HSD1 (MCF7-17βHSD1). (A) 17beta-hydroxysteroid dehydrogenase type 1 (17β-HSD1) and β-actin expression between WT MCF7 and MCF7-17βHSD1 revealed by western blots. (B) Representative two-dimensional gel images for WT MCF7 and MCF7-17βHSD1 cells. Whole cell lysates (200 µg) from each cell were separated by two-dimensional electrophoresis and visualized by Sypro Ruby staining. The two-dimensional gels were scanned and the differentially expressed (2-fold or higher, P < 0.05) proteins were detected using Progenesis software. The 18 differentially expressed protein spots that were selected for mass spectrometry (MS) analysis are marked with circles. Protein spots upregulated in MCF7-17βHSD1 are depicted in the MCF7-17βHSD1 proteome image; protein spots downregulated in MCF7-17βHSD1 are depicted in the MCF7 proteome image. The numbers refer to the spot number listed in Table 1 and Additional file 2. The squares represent the indicated area shown in more detail in (D). (C) Summary of the numbers of spots and proteins obtained from the proteomics data. *Upregulated (up) and downregulated (down) proteins in MCF7-17βHSD1 as compared to WT MCF7 cells. (D) Zoom showing some differentially expressed protein spots from WT MCF7 and MCF7-17βHSD1 comparison. Arrows indicate 17β-HSD1 protein which was revealed by MS analysis to be present in the spot numbers 2,305 (unique to MCF7-17βHSD1) and 2,300 (upregulated in MCF7-17βHSD1 as compared to WT MCF7 cells).

Back to article page